McIlrath & Eck, LLC
- SEC CIK
- 0001701714
- Latest filing
- May 19, 2026
GILD holding history
Gilead Sciences, Inc. in every 13F filed by McIlrath & Eck, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GILD overviewAll 13F holders of GILDFull Q1 2026 holdings
- Shares (Q1 2026)
- 585
- Value
- $81.6K
- % of portfolio
- <0.1%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 585 | $81.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 585 | $71.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 585 | $65.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 585 | $64.9K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 585 | $65.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2024 | 585 | $54.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2024 | 585 | $49.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2024 | 585 | $40.2K | <0.1% | −196−25.1% | Reduced | Holders |
| Q1 2024 | 781 | $57.2K | <0.1% | +231+42.0% | Added | Holders |
| Q4 2023 | 550 | $44.6K | <0.1% | +221+67.2% | Added | Holders |
| Q3 2023 | 329 | $24.7K | <0.1% | −407−55.3% | Reduced | Holders |
| Q2 2023 | 736 | $56.7K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 736 | $61.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 736 | $63.2K | <0.1% | +173+30.7% | Added | Holders |
| Q3 2022 | 563 | $35.0K | <0.1% | +58+11.5% | Added | Holders |
| Q2 2022 | 505 | $31.0K | <0.1% | −71−12.3% | Reduced | Holders |
| Q1 2022 | 576 | $34.0K | <0.1% | −5−0.9% | Reduced | Holders |
| Q4 2021 | 581 | $42.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2021 | 581 | $41.0K | <0.1% | +1+0.2% | Added | Holders |
| Q2 2021 | 580 | $40.0K | <0.1% | +1+0.2% | Added | Holders |
| Q1 2021 | 579 | $37.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.